Form 8-K - Current report:
SEC Accession No. 0001193125-25-278835
Filing Date
2025-11-13
Accepted
2025-11-13 07:35:25
Documents
11
Period of Report
2025-11-13
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K xlo-20251112.htm   iXBRL 8-K 61488
2 EX-99.1 xlo-ex99_1.htm EX-99.1 197778
  Complete submission text file 0001193125-25-278835.txt   393822

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT xlo-20251112.xsd EX-101.SCH 32060
14 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20251112_htm.xml XML 4886
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40925 | Film No.: 251475428
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)